Literature DB >> 35608835

Who Will Benefit From Metformin?

Joanne E Mortimer1, Victoria Seewaldt2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35608835     DOI: 10.1001/jamaoncol.2022.1911

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   33.006


× No keyword cloud information.
  1 in total

1.  Metformin and breast cancer: an opportunity for pharmacogenetics.

Authors:  Elisabet Cuyàs; Begoña Martin-Castillo; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2022-07-18       Impact factor: 5.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.